{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:46:13Z","timestamp":1787755573646,"version":"build-2784847793"},"reference-count":416,"publisher":"Georg Thieme Verlag KG","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Respir Crit Care Med"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bacteria within the genus Acinetobacter (principally A. baumannii\u2013calcoaceticus complex [ABC]) are gram-negative coccobacilli that most often cause infections in nosocomial settings. Community-acquired infections are rare, but may occur in patients with comorbidities, advanced age, diabetes mellitus, chronic lung or renal disease, malignancy, or impaired immunity. Most common sites of infections include blood stream, skin\/soft-tissue\/surgical wounds, ventilator-associated pneumonia, orthopaedic or neurosurgical procedures, and urinary tract. Acinetobacter species are intrinsically resistant to multiple antimicrobials, and have a remarkable ability to acquire new resistance determinants via plasmids, transposons, integrons, and resistance islands. Since the 1990s, antimicrobial resistance (AMR) has escalated dramatically among ABC. Global spread of multidrug-resistant (MDR)-ABC strains reflects dissemination of a few clones between hospitals, geographic regions, and continents; excessive antibiotic use amplifies this spread. Many isolates are resistant to all antimicrobials except colistimethate sodium and tetracyclines (minocycline or tigecycline); some infections are untreatable with existing antimicrobial agents. AMR poses a serious threat to effectively treat or prevent ABC infections. Strategies to curtail environmental colonization with MDR-ABC require aggressive infection-control efforts and cohorting of infected patients. Thoughtful antibiotic strategies are essential to limit the spread of MDR-ABC. Optimal therapy will likely require combination antimicrobial therapy with existing antibiotics as well as development of novel antibiotic classes.<\/jats:p>","DOI":"10.1055\/s-0041-1741019","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T23:32:33Z","timestamp":1645054353000},"page":"097-124","source":"Crossref","is-referenced-by-count":15,"title":["Infections Due to Acinetobacter baumannii\u2013calcoaceticus Complex: Escalation of Antimicrobial Resistance and Evolving Treatment Options"],"prefix":"10.1055","volume":"43","author":[{"suffix":"III","given":"Joseph P.","family":"Lynch","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care Medicine, Allergy, and Clinical Immunology; Department of Medicine; The David Geffen School of Medicine at UCLA, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina M.","family":"Clark","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Loyola University Medical Center, Maywood, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George G.","family":"Zhanel","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology\/Infectious Diseases, University of Manitoba, Max Rady College of Medicine, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2022,2,16]]},"reference":[{"issue":"03","key":"ref1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-0037-1599225","article-title":"Infections due to Acinetobacter baumannii in the ICU: treatment options","volume":"38","author":"J P Lynch III","year":"2017","journal-title":"Semin Respir Crit Care Med"},{"issue":"01","key":"ref2","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1186\/s12879-019-4387-3","article-title":"Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013-2017","volume":"19","author":"V Gupta","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"01","key":"ref3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.clinthera.2011.11.023","article-title":"Antimicrobial susceptibility among gram-negative isolates collected from intensive care units in North America, Europe, the Asia-Pacific Rim, Latin America, the Middle East, and Africa between 2004 and 2009 as part of the Tigecycline Evaluation and Surveillance Trial","volume":"34","author":"X Bertrand","year":"2012","journal-title":"Clin Ther"},{"issue":"07","key":"ref4","doi-asserted-by":"crossref","first-page":"e00355","DOI":"10.1128\/AAC.00355-19","article-title":"The microbiology of bloodstream infection: 20-year trends from the SENTRY Antimicrobial Surveillance Program","volume":"63","author":"D J Diekema","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"02","key":"ref5","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1128\/AAC.05620-11","article-title":"Tn125-related acquisition of blaNDM-like genes in Acinetobacter baumannii","volume":"56","author":"L Poirel","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"09","key":"ref6","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/jac\/dkr239","article-title":"Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09)","volume":"66","author":"A C Gales","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2217\/fmb-2016-0200","article-title":"Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in Greece: an extended review (2000-2015)","volume":"12","author":"T Karampatakis","year":"2017","journal-title":"Future Microbiol"},{"issue":"02","key":"ref8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.diagmicrobio.2007.09.006","article-title":"Meropenem activity against European isolates: report on the MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) 2006 results","volume":"60","author":"P J Turner","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"S 07","key":"ref9","doi-asserted-by":"crossref","first-page":"S565","DOI":"10.1093\/cid\/ciz830","article-title":"Treatment options for carbapenem-resistant gram-negative bacterial infections","volume":"69","author":"Y Doi","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"01","key":"ref10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ajic.2008.01.010","article-title":"Epidemiologic characterization of nosocomial Acinetobacter baumannii infections in a Turkish university hospital by pulsed-field gel electrophoresis","volume":"37","author":"E S Cetin","year":"2009","journal-title":"Am J Infect Control"},{"issue":"04","key":"ref11","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ijantimicag.2013.06.019","article-title":"Wide distribution of CC92 carbapenem-resistant and OXA-23-producing Acinetobacter baumannii in multiple provinces of China","volume":"42","author":"Z Ruan","year":"2013","journal-title":"Int J Antimicrob Agents"},{"issue":"01","key":"ref12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12275-013-2341-4","article-title":"Clonal spread of carbapenem resistant Acinetobacter baumannii ST92 in a Chinese Hospital during a 6-year period","volume":"51","author":"L Huang","year":"2013","journal-title":"J Microbiol"},{"issue":"07","key":"ref13","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1469-0691.2012.03967.x","article-title":"Evaluation of the effect of appropriate antimicrobial therapy on mortality associated with Acinetobacter nosocomialis bacteraemia","volume":"19","author":"S C Kuo","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"06","key":"ref14","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jmii.2014.04.009","article-title":"Antimicrobial consumption and resistance in five Gram-negative bacterial species in a hospital from 2003 to 2011","volume":"48","author":"H S Lee","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-0711-13-7","article-title":"Effects of carbapenem consumption on the prevalence of Acinetobacter infection in intensive care unit patients","volume":"13","author":"A Ogutlu","year":"2014","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"05","key":"ref16","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jiph.2018.02.003","article-title":"Antibiotic consumption versus the prevalence of multidrug-resistant Acinetobacter baumannii and Clostridium difficile infections at an ICU from 2014-2015","volume":"11","author":"G Zi\u00f3\u0142kowski","year":"2018","journal-title":"J Infect Public Health"},{"issue":"05","key":"ref17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/MCC.0000000000000337","article-title":"Emergence of antimicrobial resistance among Acinetobacter species: a global threat","volume":"22","author":"N M Clark","year":"2016","journal-title":"Curr Opin Crit Care"},{"issue":"02","key":"ref18","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/AAC.03242-14","article-title":"Characterization of plasmids in extensively drug-resistant Acinetobacter strains isolated in India and Pakistan","volume":"59","author":"L S Jones","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"01","key":"ref19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-0034-1398388","article-title":"Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options","volume":"36","author":"Y Doi","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"issue":"02","key":"ref20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/cid\/civ225","article-title":"Fatal outbreak of an emerging clone of extensively drug-resistant Acinetobacter baumannii with enhanced virulence","volume":"61","author":"C L Jones","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"04","key":"ref21","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1378\/chest.13-3065","article-title":"A 16-year prospective study of community-onset bacteremic Acinetobacter pneumonia: low mortality with appropriate initial empirical antibiotic protocols","volume":"146","author":"J S Davis","year":"2014","journal-title":"Chest"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"108248","DOI":"10.1016\/j.ijfoodmicro.2019.108248","article-title":"Pathogenic Acinetobacter species including the novel Acinetobacter dijkshoorniae recovered from market meat in Peru","volume":"305","author":"M Mar\u00ed-Almirall","year":"2019","journal-title":"Int J Food Microbiol"},{"issue":"04","key":"ref23","doi-asserted-by":"crossref","first-page":"210","DOI":"10.18683\/germs.2020.1207","article-title":"From food to hospital: we need to talk about Acinetobacter spp","volume":"10","author":"R CR Malta","year":"2020","journal-title":"Germs"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1128\/CMR.00058-16","article-title":"Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges","volume":"30","author":"D Wong","year":"2017","journal-title":"Clin Microbiol Rev"},{"issue":"03","key":"ref25","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"A P Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"03","key":"ref26","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1128\/CMR.00058-07","article-title":"Acinetobacter baumannii: emergence of a successful pathogen","volume":"21","author":"A Y Peleg","year":"2008","journal-title":"Clin Microbiol Rev"},{"issue":"04","key":"ref27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1586\/eri.13.21","article-title":"Carbapenem resistance in Acinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies","volume":"11","author":"I Abbott","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"03","key":"ref28","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jinf.2011.12.008","article-title":"Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States","volume":"64","author":"H Wisplinghoff","year":"2012","journal-title":"J Infect"},{"issue":"04","key":"ref29","first-page":"e02007","article-title":"Molecular epidemiology of emerging carbapenem resistance in Acinetobacter nosocomialis and Acinetobacter pittii in Taiwan, 2010 to 2014","volume":"63","author":"F J Chen","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"ref30","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1099\/jmm.0.000845","article-title":"Mechanisms of carbapenem resistance in Acinetobacter pittii and Acinetobacter nosocomialis isolates from Thailand","volume":"67","author":"U Singkham-In","year":"2018","journal-title":"J Med Microbiol"},{"issue":"03","key":"ref31","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.diagmicrobio.2013.03.020","article-title":"Acinetobacter pittii and Acinetobacter nosocomialis among clinical isolates of the Acinetobacter calcoaceticus-baumannii complex in Sichuan, China","volume":"76","author":"X Wang","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"01","key":"ref32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijantimicag.2011.08.006","article-title":"Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea","volume":"39","author":"Y K Park","year":"2012","journal-title":"Int J Antimicrob Agents"},{"issue":"03","key":"ref33","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1017\/S0950268811001129","article-title":"Acinetobacter calcoaceticus-Acinetobacter baumannii complex species in clinical specimens in Singapore","volume":"140","author":"T H Koh","year":"2012","journal-title":"Epidemiol Infect"},{"issue":"07","key":"ref34","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1128\/AAC.02992-14","article-title":"Clinical outcomes of hospital-acquired infection with Acinetobacter nosocomialis and Acinetobacter pittii","volume":"58","author":"S Chusri","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"01","key":"ref35","first-page":"106","article-title":"Detection of co-harboring OXA-58 and NDM-1 carbapenemase producing genes resided on a same plasmid from an Acinetobacter pittii clinical isolate in China","volume":"22","author":"Y Chen","year":"2019","journal-title":"Iran J Basic Med Sci"},{"issue":"02","key":"ref36","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3390\/microorganisms9020242","article-title":"Genomic characterization of clinical extensively drug-resistant Acinetobacter pittii isolates","volume":"9","author":"P Chopjitt","year":"2021","journal-title":"Microorganisms"},{"issue":"04","key":"ref37","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/jac\/dkq521","article-title":"Species identification and molecular characterization of Acinetobacter spp. blood culture isolates from Norway","volume":"66","author":"N Karah","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"03","key":"ref38","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/cid\/ciq154","article-title":"Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with Acinetobacter bacteremia","volume":"52","author":"Y C Chuang","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"10","key":"ref39","doi-asserted-by":"crossref","first-page":"e46984","DOI":"10.1371\/journal.pone.0046984","article-title":"The success of Acinetobacter species; genetic, metabolic and virulence attributes","volume":"7","author":"A Y Peleg","year":"2012","journal-title":"PLoS One"},{"issue":"06","key":"ref40","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijantimicag.2015.03.001","article-title":"Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology","volume":"45","author":"A Potron","year":"2015","journal-title":"Int J Antimicrob Agents"},{"issue":"03","key":"ref41","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/1040841X.2019.1600472","article-title":"Recent perspectives on the virulent factors and treatment options for multidrug-resistant Acinetobacter baumannii","volume":"45","author":"S Skariyachan","year":"2019","journal-title":"Crit Rev Microbiol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.3389\/fmicb.2016.01210","article-title":"Identification of novel genomic islands in Liverpool epidemic strain of Pseudomonas aeruginosa using segmentation and clustering","volume":"7","author":"M Jani","year":"2016","journal-title":"Front Microbiol"},{"issue":"02","key":"ref43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrmicro.2017.148","article-title":"Uncovering the mechanisms of Acinetobacter baumannii virulence","volume":"16","author":"C M Harding","year":"2018","journal-title":"Nat Rev Microbiol"},{"issue":"03","key":"ref44","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/jac\/dkv378","article-title":"Prevalence of hypermutators among clinical Acinetobacter baumannii isolates","volume":"71","author":"P Komp Lindgren","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"04","key":"ref45","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jmii.2012.12.004","article-title":"The sensor kinase BfmS mediates virulence in Acinetobacter baumannii","volume":"47","author":"M L Liou","year":"2014","journal-title":"J Microbiol Immunol Infect"},{"issue":"01","key":"ref46","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/21505594.2018.1558693","article-title":"The Acinetobacter trimeric autotransporter adhesin Ata controls key virulence traits of Acinetobacter baumannii","volume":"10","author":"M Weidensdorfer","year":"2019","journal-title":"Virulence"},{"issue":"01","key":"ref47","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jhin.2019.09.021","article-title":"Genetics, epidemiology, and clinical manifestations of multidrug-resistant Acinetobacter baumannii","volume":"104","author":"P Nasr","year":"2020","journal-title":"J Hosp Infect"},{"issue":"03","key":"ref48","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"E Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"07","key":"ref49","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1469-0691.2012.03988.x","article-title":"Bacteremic nosocomial pneumonia caused by Acinetobacter baumannii and Acinetobacter nosocomialis: a single or two distinct clinical entities?","volume":"19","author":"Y T Lee","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"04","key":"ref50","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.cmi.2015.12.010","article-title":"Bloodstream infection caused by extensively drug-resistant Acinetobacter baumannii in cancer patients: high mortality associated with delayed treatment rather than with the degree of neutropenia","volume":"22","author":"M P Freire","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"02","key":"ref51","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ajic.2013.09.003","article-title":"Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii: risk factors, clinical features, and outcomes","volume":"42","author":"E S \u00d6zg\u00fcr","year":"2014","journal-title":"Am J Infect Control"},{"issue":"06","key":"ref52","first-page":"SC06","article-title":"Ventilator-associated pneumonia: incidence, risk factors and outcome in paediatric intensive care units at Cairo University Hospital","volume":"10","author":"Y S Galal","year":"2016","journal-title":"J Clin Diagn Res"},{"issue":"01","key":"ref53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/668770","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010","volume":"34","author":"D M Sievert","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"09","key":"ref54","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s00701-016-2890-5","article-title":"Nosocomial bloodstream infections in neurosurgery: a 10-year analysis in a center with high antimicrobial drug-resistance prevalence","volume":"158","author":"P P Tsitsopoulos","year":"2016","journal-title":"Acta Neurochir (Wien)"},{"issue":"06","key":"ref55","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jiph.2015.04.028","article-title":"Device-associated infection rates and bacterial resistance in six academic teaching hospitals of Iran: findings from the International Nocosomial Infection Control Consortium (INICC)","volume":"8","author":"S Jahani-Sherafat","year":"2015","journal-title":"J Infect Public Health"},{"issue":"04","key":"ref56","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ijantimicag.2016.01.015","article-title":"Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii","volume":"47","author":"S H Lob","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/978-1-4939-9118-1_25","article-title":"Skin and soft tissue models for Acinetobacter baumannii infection","volume":"1946","author":"D V Zurawski","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"02","key":"ref58","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.burns.2013.06.003","article-title":"Antibiotic resistance and OXA-type carbapenemases-encoding genes in airborne Acinetobacter baumannii isolated from burn wards","volume":"40","author":"J Gao","year":"2014","journal-title":"Burns"},{"issue":"05","key":"ref59","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.burns.2013.11.003","article-title":"Nosocomial infection characteristics in a burn intensive care unit: analysis of an eleven-year active surveillance","volume":"40","author":"O \u00d6nc\u00fcl","year":"2014","journal-title":"Burns"},{"issue":"03","key":"ref60","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jhin.2017.07.020","article-title":"Incidence, risk factors, and outcome of multidrug-resistant Acinetobacter baumannii acquisition during an outbreak in a burns unit","volume":"97","author":"A L Munier","year":"2017","journal-title":"J Hosp Infect"},{"issue":"06","key":"ref61","first-page":"804","article-title":"Evaluation of post-operative meningitis: comparison of meningitis caused by Acinetobacter spp. and other possible causes","volume":"29","author":"G C Senturk","year":"2019","journal-title":"Turk Neurosurg"},{"issue":"04","key":"ref62","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s15010-018-1234-1","article-title":"Acinetobacter baumannii meningitis in children: a case series and literature review","volume":"47","author":"J Xiao","year":"2019","journal-title":"Infection"},{"issue":"07","key":"ref63","doi-asserted-by":"crossref","first-page":"e572","DOI":"10.1016\/j.ijid.2009.06.032","article-title":"Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature","volume":"14","author":"A Cascio","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"06","key":"ref64","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ijantimicag.2013.02.006","article-title":"Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review","volume":"41","author":"I Karaiskos","year":"2013","journal-title":"Int J Antimicrob Agents"},{"issue":"S 01","key":"ref65","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bjm.2018.04.002","article-title":"Bacteremia and meningitis caused by OXA-23-producing Acinetobacter baumannii - molecular characterization and susceptibility testing for alternative antibiotics","volume":"49","author":"K F Schuertz","year":"2018","journal-title":"Braz J Microbiol"},{"issue":"02","key":"ref66","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.3171\/2019.5.FOCUS19278","article-title":"Outcome following postneurosurgical Acinetobacter meningitis: an institutional experience of 72 cases","volume":"47","author":"R Sharma","year":"2019","journal-title":"Neurosurg Focus"},{"issue":"01","key":"ref67","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4103\/jcrt.JCRT_737_17","article-title":"Increasing rates of Acinetobacter baumannii infection and resistance in an oncology department","volume":"14","author":"L Fan","year":"2018","journal-title":"J Cancer Res Ther"},{"issue":"05","key":"ref68","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jcrc.2011.04.007","article-title":"Acinetobacter baumannii infection in patients with hematologic malignancies in intensive care unit: risk factors and impact on mortality","volume":"26","author":"M Turkoglu","year":"2011","journal-title":"J Crit Care"},{"issue":"09","key":"ref69","doi-asserted-by":"crossref","first-page":"e2943","DOI":"10.1097\/MD.0000000000002943","article-title":"Risk factors and clinical outcomes for patients with Acinetobacter baumannii bacteremia","volume":"95","author":"Z Gu","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"07","key":"ref70","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s10096-016-2895-2","article-title":"Acinetobacter baumannii bacteraemia in patients with haematological malignancy: a multicentre retrospective study from the Infection Working Party of Jiangsu Society of Hematology","volume":"36","author":"X Wang","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"02","key":"ref71","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.bj.2015.07.001","article-title":"Risk factors of multidrug-resistant Acinetobacter baumannii recurrence after successful eradication in ventilated patients","volume":"39","author":"C Y Lin","year":"2016","journal-title":"Biomed J"},{"issue":"01","key":"ref72","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s15010-011-0187-4","article-title":"Clinical characteristics and outcomes of bacteremia due to different genomic species of Acinetobacter baumannii complex in patients with solid tumors","volume":"40","author":"M C Chiang","year":"2012","journal-title":"Infection"},{"issue":"12","key":"ref73","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.ajic.2013.04.003","article-title":"Risk factors for acquisition of multidrug-resistant Acinetobacter baumannii among cancer patients","volume":"41","author":"Y Fukuta","year":"2013","journal-title":"Am J Infect Control"},{"issue":"05","key":"ref74","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jmii.2011.12.009","article-title":"Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia","volume":"45","author":"S T Huang","year":"2012","journal-title":"J Microbiol Immunol Infect"},{"issue":"01","key":"ref75","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ajic.2013.06.017","article-title":"Case-control analysis of endemic Acinetobacter baumannii bacteremia in the neonatal intensive care unit","volume":"42","author":"J F Hsu","year":"2014","journal-title":"Am J Infect Control"},{"issue":"01","key":"ref76","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/jhin.2002.1205","article-title":"Hospital-acquired infections following the 1999 Marmara earthquake","volume":"51","author":"O Onc\u00fcl","year":"2002","journal-title":"J Hosp Infect"},{"issue":"05","key":"ref77","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/01.CCM.0000163269.42524.50","article-title":"The long-distance tertiary air transfer and care of tsunami victims: injury pattern and microbiological and psychological aspects","volume":"33","author":"M Maegele","year":"2005","journal-title":"Crit Care Med"},{"issue":"06","key":"ref78","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1086\/517956","article-title":"Importation of Acinetobacter baumannii into a burn unit: a recurrent outbreak of infection associated with widespread environmental contamination","volume":"28","author":"G Zanetti","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"03","key":"ref79","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/505601","article-title":"Acinetobacter infection: what was the true impact during the Vietnam conflict?","volume":"43","author":"C K Murray","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"04","key":"ref80","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/01.ASW.0000363527.08501.a3","article-title":"Insights into Acinetobacter war-wound infections, biofilms, and control","volume":"23","author":"S F Dallo","year":"2010","journal-title":"Adv Skin Wound Care"},{"issue":"12","key":"ref81","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1056\/NEJMra070741","article-title":"Acinetobacter infection","volume":"358","author":"L S Munoz-Price","year":"2008","journal-title":"N Engl J Med"},{"issue":"01","key":"ref82","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1128\/JCM.00766-10","article-title":"Diversity and clinical impact of Acinetobacter baumannii colonization and infection at a military medical center","volume":"49","author":"K Petersen","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"03","key":"ref83","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1089\/sur.2017.240","article-title":"Early infections complicating the care of combat casualties from Iraq and Afghanistan","volume":"19","author":"A C Weintrob","year":"2018","journal-title":"Surg Infect (Larchmt)"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13756-019-0612-5","article-title":"Study of genetic diversity, biofilm formation, and detection of carbapenemase, MBL, ESBL, and tetracycline resistance genes in multidrug-resistant Acinetobacter baumannii isolated from burn wound infections in Iran","volume":"8","author":"R Ranjbar","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"issue":"01","key":"ref85","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1128\/genomeA.01678-15","article-title":"Draft genome sequences of Acinetobacter baumannii strains harboring the blaNDM-1 gene isolated in Lebanon from civilians wounded during the Syrian Civil War","volume":"4","author":"S Tokajian","year":"2016","journal-title":"Genome Announc"},{"issue":"02","key":"ref86","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1556\/1886.2016.00014","article-title":"Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii complex isolates from patients that were injured during the Eastern Ukrainian conflict","volume":"6","author":"H Granzer","year":"2016","journal-title":"Eur J Microbiol Immunol (Bp)"},{"issue":"10","key":"ref87","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2307\/30141099","article-title":"Molecular heterogeneity of Acinetobacter baumannii isolates during seasonal increase in prevalence","volume":"16","author":"C Christie","year":"1995","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"05","key":"ref88","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1586\/14787210.2015.1025055","article-title":"Community-acquired Acinetobacter baumannii: clinical characteristics, epidemiology and pathogenesis","volume":"13","author":"C Dexter","year":"2015","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"01","key":"ref89","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1378\/chest.129.1.102","article-title":"Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome","volume":"129","author":"W S Leung","year":"2006","journal-title":"Chest"},{"issue":"04","key":"ref90","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1378\/chest.120.4.1072","article-title":"Severe community-acquired pneumonia due to Acinetobacter baumannii","volume":"120","author":"M Z Chen","year":"2001","journal-title":"Chest"},{"issue":"02","key":"ref91","first-page":"186","article-title":"Case series: fulminant community-acquired Acinetobacter pneumonia","volume":"75","author":"S Tonnii","year":"2020","journal-title":"Med J Malaysia"},{"issue":"01","key":"ref92","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12879-019-4733-5","article-title":"Diagnosis of severe community-acquired pneumonia caused by Acinetobacter baumannii through next-generation sequencing: a case report","volume":"20","author":"A Xu","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"03","key":"ref93","doi-asserted-by":"crossref","first-page":"ofy044","DOI":"10.1093\/ofid\/ofy044","article-title":"Severe community-acquired pneumonia due to Acinetobacter baumannii in North America: case report and review of the literature","volume":"5","author":"D P Serota","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"01","key":"ref94","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/s12879-017-2589-0","article-title":"First report of cavitary pneumonia due to community-acquired Acinetobacter pittii, study of virulence and overview of pathogenesis and treatment","volume":"17","author":"R Larcher","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"08","key":"ref95","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jiac.2019.03.016","article-title":"Clinical manifestations and risk factors of community-onset Acinetobacter species pneumonia in Japan; case control study in a single institute in Japan","volume":"25","author":"N Asai","year":"2019","journal-title":"J Infect Chemother"},{"issue":"02","key":"ref96","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1128\/JCM.40.2.685-686.2002","article-title":"Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groups","volume":"40","author":"N M Anstey","year":"2002","journal-title":"J Clin Microbiol"},{"issue":"12","key":"ref97","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s10096-007-0365-6","article-title":"Community-acquired Acinetobacter infections","volume":"26","author":"M E Falagas","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"02","key":"ref98","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijantimicag.2011.10.004","article-title":"Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options","volume":"39","author":"M Kempf","year":"2012","journal-title":"Int J Antimicrob Agents"},{"issue":"05","key":"ref99","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ajic.2015.11.036","article-title":"Control of endemic extensively drug-resistant Acinetobacter baumannii with a cohorting policy and cleaning procedures based on the 1 room, 1 wipe approach","volume":"44","author":"L Gavald\u00e0","year":"2016","journal-title":"Am J Infect Control"},{"issue":"12","key":"ref100","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s00134-015-4079-4","article-title":"Task force on management and prevention of Acinetobacter baumannii infections in the ICU","volume":"41","author":"J Garnacho-Montero","year":"2015","journal-title":"Intensive Care Med"},{"issue":"11","key":"ref101","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1086\/521660","article-title":"Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit","volume":"28","author":"L S Young","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"06","key":"ref102","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3855\/jidc.6726","article-title":"Genetic relatedness of clinical and environmental Acinetobacter baumannii isolates from an intensive care unit outbreak","volume":"9","author":"A Senok","year":"2015","journal-title":"J Infect Dev Ctries"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13756-018-0326-0","article-title":"Colonization of long-term care facility residents in three Italian Provinces by multidrug-resistant bacteria","volume":"7","author":"E Nucleo","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"issue":"01","key":"ref104","doi-asserted-by":"crossref","first-page":"ofv023","DOI":"10.1093\/ofid\/ofv023","article-title":"Acinetobacter infections and outcomes at an academic medical center: a disease of long-term care","volume":"2","author":"J Townsend","year":"2015","journal-title":"Open Forum Infect Dis"},{"issue":"03","key":"ref105","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jmii.2017.08.001","article-title":"Clonal spread of carbapenem-resistant Acinetobacter baumannii across a community hospital and its affiliated long-term care facilities: a cross sectional study","volume":"51","author":"C H Chen","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"issue":"07","key":"ref106","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ajic.2017.02.005","article-title":"Persistent nasal carriers of Acinetobacter baumannii in long-term-care facilities","volume":"45","author":"M L Liou","year":"2017","journal-title":"Am J Infect Control"},{"issue":"10","key":"ref107","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1128\/AAC.00669-16","article-title":"Acquisition of a high diversity of bacteria during the Hajj Pilgrimage, including Acinetobacter baumannii with blaOXA-72 and Escherichia coli with blaNDM-5 carbapenemase genes","volume":"60","author":"T Leangapichart","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"08","key":"ref108","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/jac\/dkq191","article-title":"Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination","volume":"65","author":"F Perez","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.micpath.2018.02.025","article-title":"Microbial infection pattern, pathogenic features and resistance mechanism of carbapenem-resistant Gram negative bacilli during long-term hospitalization","volume":"117","author":"S Wen","year":"2018","journal-title":"Microb Pathog"},{"issue":"48","key":"ref110","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.15585\/mmwr.mm6948e1","article-title":"Increase in hospital-acquired carbapenem-resistant Acinetobacter baumannii infection and colonization in an acute care hospital during a surge in COVID-19 admissions - New Jersey, February-July 2020","volume":"69","author":"S Perez","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"04","key":"ref111","doi-asserted-by":"crossref","first-page":"e0195757","DOI":"10.1371\/journal.pone.0195757","article-title":"Carbapenem-resistant Gram-negative pathogens in a German university medical center: prevalence, clinical implications and the role of novel \u03b2-lactam\/\u03b2-lactamase inhibitor combinations","volume":"13","author":"J Katchanov","year":"2018","journal-title":"PLoS One"},{"issue":"08","key":"ref112","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1469-0691.2010.03420.x","article-title":"Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit","volume":"17","author":"S Nseir","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"08","key":"ref113","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/cid\/cir090","article-title":"Is central venous catheter tips' colonization with multi-drug resistant Acinetobacter baumannii a predictor for bacteremia?","volume":"52","author":"A Apisarnthanarak","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"02","key":"ref114","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3855\/jidc.8081","article-title":"Use of carbapenems and glycopeptides is significant risk for multidrug resistant Acinetobacter baumannii infections","volume":"12","author":"S Hosoglu","year":"2018","journal-title":"J Infect Dev Ctries"},{"issue":"08","key":"ref115","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jiac.2015.04.010","article-title":"Risk factors of multidrug-resistant, extensively drug-resistant and pandrug-resistant Acinetobacter baumannii ventilator-associated pneumonia in a Medical Intensive Care Unit of University Hospital in Thailand","volume":"21","author":"J Inchai","year":"2015","journal-title":"J Infect Chemother"},{"issue":"09","key":"ref116","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.eimc.2015.11.018","article-title":"Acinetobacter baumannii in critically ill patients: molecular epidemiology, clinical features and predictors of mortality","volume":"34","author":"J Garnacho-Montero","year":"2016","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"09","key":"ref117","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1177\/0885066616632193","article-title":"Multidrug resistance Acinetobacter bacteremia secondary to ventilator-associated pneumonia: risk factors and outcome","volume":"32","author":"E Brotfain","year":"2017","journal-title":"J Intensive Care Med"},{"issue":"10","key":"ref118","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s10096-015-2452-4","article-title":"Risk factors for and impact of carbapenem-resistant Acinetobacter baumannii colonization and infection: matched case-control study","volume":"34","author":"O Henig","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"21","key":"ref119","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.2009.1754","article-title":"International study of the prevalence and outcomes of infection in intensive care units","volume":"302","author":"J L Vincent","year":"2009","journal-title":"JAMA"},{"issue":"10","key":"ref120","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1128\/AAC.01728-10","article-title":"Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infections","volume":"55","author":"J S Esterly","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"01","key":"ref121","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s13054-016-1392-4","article-title":"Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsis","volume":"20","author":"M D Zilberberg","year":"2016","journal-title":"Crit Care"},{"issue":"05","key":"ref122","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1128\/AAC.02656-15","article-title":"Clinical and epidemiological significance of carbapenem resistance in Acinetobacter baumannii infections","volume":"60","author":"R Tal-Jasper","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"05","key":"ref123","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/1469-0691.12363","article-title":"Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis","volume":"20","author":"E V Lemos","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"01","key":"ref124","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13756-015-0043-x","article-title":"Extensively drug-resistant Acinetobacter baumannii in a Thai hospital: a molecular epidemiologic analysis and identification of bactericidal polymyxin B-based combinations","volume":"4","author":"J Teo","year":"2015","journal-title":"Antimicrob Resist Infect Control"},{"issue":"02","key":"ref125","doi-asserted-by":"crossref","first-page":"90","DOI":"10.26719\/emhj.18.015","article-title":"Assessment of device-associated infection rates in teaching hospitals in Islamic Republic of Iran","volume":"25","author":"S Afhami","year":"2019","journal-title":"East Mediterr Health J"},{"issue":"04","key":"ref126","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.diagmicrobio.2013.11.025","article-title":"Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011)","volume":"78","author":"H S Sader","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"05","key":"ref127","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s15010-009-9003-9","article-title":"Carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme: dissemination in Southern Brazil","volume":"37","author":"A F Martins","year":"2009","journal-title":"Infection"},{"issue":"05","key":"ref128","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ajic.2015.11.020","article-title":"ISAba1\/blaOXA-23: a serious obstacle to controlling the spread and treatment of Acinetobacter baumannii strains","volume":"44","author":"G F Viana","year":"2016","journal-title":"Am J Infect Control"},{"issue":"12","key":"ref129","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1164\/rccm.201102-0349OC","article-title":"High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia","volume":"184","author":"D R Chung","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"04","key":"ref130","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.diagmicrobio.2013.08.011","article-title":"Risk factors for hospital-acquired pneumonia caused by carbapenem-resistant Gram-negative bacteria in critically ill patients: a multicenter study in Korea","volume":"78","author":"T Kim","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"03","key":"ref131","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0732-8893(02)00468-6","article-title":"Skin and soft tissue infections in Latin American medical centers: four-year assessment of the pathogen frequency and antimicrobial susceptibility patterns","volume":"44","author":"H S Sader","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"27","key":"ref132","doi-asserted-by":"crossref","first-page":"e4099","DOI":"10.1097\/MD.0000000000004099","article-title":"High prevalence of hospital-acquired infections caused by gram-negative carbapenem resistant strains in Vietnamese pediatric ICUs: a multi-centre point prevalence survey","volume":"95","author":"N K Le","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"01","key":"ref133","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12879-017-2932-5","article-title":"A multi-center study on the risk factors of infection caused by multi-drug resistant Acinetobacter baumannii","volume":"18","author":"H Huang","year":"2018","journal-title":"BMC Infect Dis"},{"key":"ref134","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.2147\/IDR.S215329","article-title":"Evaluating the antimicrobial resistance patterns among major bacterial pathogens isolated from clinical specimens taken from patients in Mofid Children's Hospital, Tehran, Iran: 2013-2018","volume":"12","author":"T Azimi","year":"2019","journal-title":"Infect Drug Resist"},{"issue":"01","key":"ref135","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13054-018-2013-1","article-title":"Epidemiology of sepsis in intensive care units in Turkey: a multicenter, point-prevalence study","volume":"22","author":"N Baykara","year":"2018","journal-title":"Crit Care"},{"issue":"04","key":"ref136","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ajic.2015.10.031","article-title":"Device-associated infection rates, bacterial resistance, length of stay, and mortality in Kuwait: International Nosocomial Infection Consortium findings","volume":"44","author":"H H Al-Mousa","year":"2016","journal-title":"Am J Infect Control"},{"issue":"05","key":"ref137","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1089\/mdr.2015.0032","article-title":"Characteristics and outcomes of Acinetobacter baumannii infections in critically ill patients with cancer: a matched case-control study","volume":"21","author":"L H Nazer","year":"2015","journal-title":"Microb Drug Resist"},{"issue":"04","key":"ref138","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2174\/1566524019666190321113008","article-title":"Integrons and antiseptic resistance genes mediate resistance of Acinetobacter baumannii and Pseudomonas aeruginosa isolates from intensive care unit patients with wound infections","volume":"19","author":"W F Elkhatib","year":"2019","journal-title":"Curr Mol Med"},{"issue":"03","key":"ref139","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"H Wisplinghoff","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"09","key":"ref140","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1089\/mdr.2019.0002","article-title":"Multidrug- and extensively drug-resistant Acinetobacter baumannii in a tertiary hospital from Brazil: the importance of carbapenemase encoding genes and epidemic clonal complexes in a 10-year study","volume":"25","author":"P Romanin","year":"2019","journal-title":"Microb Drug Resist"},{"issue":"06","key":"ref141","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/jac\/dkl130","article-title":"Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy","volume":"57","author":"M E Falagas","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"ref142","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1186\/s12879-014-0572-6","article-title":"Predictors of hospital mortality among septic ICU patients with Acinetobacter spp. bacteremia: a cohort study","volume":"14","author":"A F Shorr","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"10","key":"ref143","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1099\/jmm.0.000328","article-title":"Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in South America","volume":"65","author":"C H Rodr\u00edguez","year":"2016","journal-title":"J Med Microbiol"},{"key":"ref144","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/s12879-016-1695-8","article-title":"Acinetobacter spp. are associated with a higher mortality in intensive care patients with bacteremia: a survival analysis","volume":"16","author":"A C Le\u00e3o","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"12","key":"ref145","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1128\/AAC.00856-09","article-title":"OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii","volume":"53","author":"P G Higgins","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"01","key":"ref146","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijantimicag.2008.12.009","article-title":"Dissemination of multidrug-resistant Acinetobacter baumannii genotypes carrying bla(OXA-23) collected from hospitals in Rio de Janeiro, Brazil","volume":"34","author":"K R Carvalho","year":"2009","journal-title":"Int J Antimicrob Agents"},{"issue":"03","key":"ref147","first-page":"235","article-title":"Polyclonal spread of bla(OXA-23) and bla(OXA-58) in Acinetobacter baumannii isolates from Argentina","volume":"2","author":"A K Merkier","year":"2008","journal-title":"J Infect Dev Ctries"},{"issue":"04","key":"ref148","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3855\/jidc.2310","article-title":"OXA-type carbapenemases in Acinetobacter baumannii in South America","volume":"6","author":"A Opazo","year":"2012","journal-title":"J Infect Dev Ctries"},{"issue":"12","key":"ref149","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1007\/s00134-012-2695-9","article-title":"Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study","volume":"38","author":"A Tabah","year":"2012","journal-title":"Intensive Care Med"},{"issue":"12","key":"ref150","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1093\/jac\/dkx322","article-title":"High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial","volume":"72","author":"J Nowak","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"ref151","first-page":"1","article-title":"Carbapenem resistant bacteria in intensive care unit during COVID-19 pandemic: multicenter before-after cross sectional study","author":"R Pascale","year":"2021","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"06","key":"ref152","doi-asserted-by":"crossref","first-page":"e02562","DOI":"10.1128\/AAC.02562-17","article-title":"Comparison of septic shock due to multidrug-resistant Acinetobacter baumannii or Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in intensive care unit patients","volume":"62","author":"A Russo","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"05","key":"ref153","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/CCM.0000000000000125","article-title":"Risk factors and outcome analysis of Acinetobacter baumannii complex bacteremia in critical patients","volume":"42","author":"H Y Lee","year":"2014","journal-title":"Crit Care Med"},{"issue":"11","key":"ref154","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1086\/591861","article-title":"NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007","volume":"29","author":"A I Hidron","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"12","key":"ref155","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s10096-015-2495-6","article-title":"COPD patients with ventilator-associated pneumonia: implications for management","volume":"34","author":"D Koulenti","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"03","key":"ref156","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7883\/yoken.JJID.2014.282","article-title":"Ventilator-associated pneumonia: epidemiology and prognostic indicators of 30-day mortality","volume":"68","author":"J Inchai","year":"2015","journal-title":"Jpn J Infect Dis"},{"issue":"07","key":"ref157","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.ajic.2013.01.006","article-title":"Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia","volume":"41","author":"Y L Zheng","year":"2013","journal-title":"Am J Infect Control"},{"key":"ref158","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1471-2334-13-119","article-title":"Epidemiology and outcomes of ventilator-associated pneumonia in northern Brazil: an analytical descriptive prospective cohort study","volume":"13","author":"M M Resende","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"06","key":"ref159","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jinf.2019.09.012","article-title":"The global prevalence of multidrug-resistance among Acinetobacter baumannii causing hospital-acquired and ventilator-associated pneumonia and its associated mortality: a systematic review and meta-analysis","volume":"79","author":"S Mohd Sazlly Lim","year":"2019","journal-title":"J Infect"},{"issue":"03","key":"ref160","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jhin.2006.10.012","article-title":"Device-associated hospital-acquired infection rates in Turkish intensive care units","volume":"65","author":"H Leblebicioglu","year":"2007","journal-title":"J Hosp Infect"},{"issue":"06","key":"ref161","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1086\/432803","article-title":"Overview of nosocomial infections caused by gram-negative bacilli","volume":"41","author":"R Gaynes","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref162","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1186\/1471-2334-13-561","article-title":"A comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study","volume":"13","author":"A A Quartin","year":"2013","journal-title":"BMC Infect Dis"},{"issue":"05","key":"ref163","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/cid\/cir895","article-title":"Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study","volume":"54","author":"R G Wunderink","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"03","key":"ref164","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.diagmicrobio.2010.10.030","article-title":"Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study","volume":"69","author":"M McCracken","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref165","first-page":"iv2","article-title":"Canadian Antimicrobial Resistance Alliance (CARA) and CANWARD","volume":"74","author":"G G Zhanel","year":"2019","journal-title":"Ten Years of the CANWARD Study (2007-16) J Antimicrob Chemother"},{"issue":"11","key":"ref166","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1007\/s10096-016-2703-z","article-title":"Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP\/CAP study","volume":"36","author":"D Koulenti","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"01","key":"ref167","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10096-019-03691-z","article-title":"Treatment of ventilator-associated pneumonia (VAP) caused by Acinetobacter: results of prospective and multicenter ID-IRI study","volume":"39","author":"H Erdem","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"07","key":"ref168","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/1120009X.2020.1793594","article-title":"Gram-negative bacteria as causative agents of ventilator-associated pneumonia and their respective resistance mechanisms","volume":"32","author":"D Bandi\u0107-Pavlovi\u0107","year":"2020","journal-title":"J Chemother"},{"issue":"02","key":"ref169","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/resp.12698","article-title":"Nosocomial Acinetobacter pneumonia: treatment and prognostic factors in 356 cases","volume":"21","author":"T \u00d6zvatan","year":"2016","journal-title":"Respirology"},{"key":"ref170","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/j.ajic.2007.05.011","article-title":"Epidemiology, etiology, and diagnosis of hospital-acquired pneumonia and ventilator-associated pneumonia in Asian countries","volume":"36","author":"R Chawla","year":"2008","journal-title":"Am J Infect Control"},{"issue":"01","key":"ref171","doi-asserted-by":"crossref","first-page":"15279","DOI":"10.1038\/s41598-017-13148-y","article-title":"Bacteremic and non-bacteremic pneumonia caused by Acinetobacter baumannii in ICUs of South China: a clinical and microbiological study","volume":"7","author":"Y Tan","year":"2017","journal-title":"Sci Rep"},{"key":"ref172","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fphar.2019.00092","article-title":"Acinetobacter baumannii ventilator-associated pneumonia: clinical efficacy of combined antimicrobial therapy and in vitro drug sensitivity test results","volume":"10","author":"Y Huang","year":"2019","journal-title":"Front Pharmacol"},{"key":"ref173","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1515\/med-2019-0090","article-title":"Risk factors and drug resistance of the MDR Acinetobacter baumannii in pneumonia patients in ICU","volume":"14","author":"J Ren","year":"2019","journal-title":"Open Med (Wars)"},{"key":"ref174","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.micpath.2018.12.023","article-title":"Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients","volume":"128","author":"M Jain","year":"2019","journal-title":"Microb Pathog"},{"issue":"02","key":"ref175","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1473-3099(20)30731-3","article-title":"Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial","volume":"21","author":"R G Wunderink","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"02","key":"ref176","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1473-3099(20)30796-9","article-title":"Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial","volume":"21","author":"M Bassetti","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"ref177","first-page":"13","article-title":"Burns infection profile of Singapore: prevalence of multidrug-resistant Acinetobacter baumannii and the role of blood cultures","volume":"4","author":"C T Song","year":"2016","journal-title":"Burns Trauma"},{"issue":"10","key":"ref178","first-page":"638","article-title":"Identification of genomic species of Acinetobacter isolated from burns of ICU patients","volume":"18","author":"N Shaykh Baygloo","year":"2015","journal-title":"Arch Iran Med"},{"issue":"10","key":"ref179","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/wound.2018.0854","article-title":"Efficacy of poloxamer-based wound dressings on Acinetobacter baumannii biofilms","volume":"8","author":"A M Salisbury","year":"2019","journal-title":"Adv Wound Care (New Rochelle)"},{"issue":"03","key":"ref180","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/TA.0000000000001338","article-title":"Modeling Acinetobacter baumannii wound infections: the critical role of iron","volume":"82","author":"I D Fleming","year":"2017","journal-title":"J Trauma Acute Care Surg"},{"issue":"11","key":"ref181","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.ajic.2017.06.016","article-title":"Multidrug-resistant Acinetobacter: risk factors and outcomes in veterans with spinal cord injuries and disorders","volume":"45","author":"S Ramanathan","year":"2017","journal-title":"Am J Infect Control"},{"issue":"03","key":"ref182","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1128\/microbiolspec.ARBA-0007-2017","article-title":"Antimicrobial resistance in Acinetobacter spp. and Pseudomonas spp","volume":"6","author":"A Lupo","year":"2018","journal-title":"Microbiol Spectr"},{"key":"ref183","doi-asserted-by":"crossref","first-page":"249856","DOI":"10.1155\/2014\/249856","article-title":"Worldwide dissemination of the NDM-type carbapenemases in Gram-negative bacteria","volume":"2014","author":"L Dortet","year":"2014","journal-title":"BioMed Res Int"},{"issue":"03","key":"ref184","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/2049-632X.12125","article-title":"Acinetobacter baumannii: evolution of a global pathogen","volume":"71","author":"L C Antunes","year":"2014","journal-title":"Pathog Dis"},{"issue":"04","key":"ref185","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.bjm.2016.06.005","article-title":"Mobile genetic elements related to carbapenem resistance in Acinetobacter baumannii","volume":"47","author":"M Pagano","year":"2016","journal-title":"Braz J Microbiol"},{"key":"ref186","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.meegid.2018.10.022","article-title":"Distinct role of outer membrane protein A in the intrinsic resistance of Acinetobacter baumannii and Acinetobacter nosocomialis","volume":"67","author":"H I Kwon","year":"2019","journal-title":"Infect Genet Evol"},{"key":"ref187","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2147\/IDR.S228089","article-title":"Acinetobacter baumannii efflux pumps and antibiotic resistance","volume":"13","author":"S N Abdi","year":"2020","journal-title":"Infect Drug Resist"},{"issue":"04","key":"ref188","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s00253-019-10317-z","article-title":"Stress responses linked to antimicrobial resistance in Acinetobacter species","volume":"104","author":"B Shin","year":"2020","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref189","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2147\/IDR.S169894","article-title":"Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments","volume":"11","author":"E C Eze","year":"2018","journal-title":"Infect Drug Resist"},{"issue":"12","key":"ref190","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.tim.2011.09.005","article-title":"The emerging NDM carbapenemases","volume":"19","author":"P Nordmann","year":"2011","journal-title":"Trends Microbiol"},{"key":"ref191","first-page":"129","article-title":"Molecular typing of XDR Acinetobacter baumannii strains in an Italian ICU","volume":"39","author":"A Piana","year":"2015","journal-title":"Epidemiol Prev"},{"issue":"04","key":"ref192","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1089\/mdr.2004.10.286","article-title":"Genotypic characterization of carbapenem-nonsusceptible Acinetobacter spp. isolated in Latin America","volume":"10","author":"A C Gales","year":"2004","journal-title":"Microb Drug Resist"},{"key":"ref193","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1099\/jmm.0.05445-0","article-title":"Long-term predominance of two pan-European clones among multi-resistant Acinetobacter baumannii strains in the Czech Republic","volume":"53","author":"A Nemec","year":"2004","journal-title":"J Med Microbiol"},{"issue":"10","key":"ref194","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1128\/AAC.41.10.2265","article-title":"Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study","volume":"41","author":"H Vahaboglu","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"issue":"05","key":"ref195","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1574-6976.2011.00268.x","article-title":"Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance","volume":"35","author":"N Woodford","year":"2011","journal-title":"FEMS Microbiol Rev"},{"issue":"11","key":"ref196","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1128\/JCM.01208-10","article-title":"Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a single institution over a 10-year period","volume":"48","author":"N Runnegar","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"04","key":"ref197","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.drup.2012.06.001","article-title":"Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii","volume":"15","author":"N Karah","year":"2012","journal-title":"Drug Resist Updat"},{"issue":"02","key":"ref198","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/jac\/dkp428","article-title":"Global spread of carbapenem-resistant Acinetobacter baumannii","volume":"65","author":"P G Higgins","year":"2010","journal-title":"J Antimicrob Chemother"},{"issue":"03","key":"ref199","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/jac\/dkn205","article-title":"Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II","volume":"62","author":"A Nemec","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"ref200","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1128\/JCM.01759-12","article-title":"Molecular epidemiology of Acinetobacter baumannii bloodstream isolates obtained in the United States from 1995 to 2004 using rep-PCR and multilocus sequence typing","volume":"50","author":"P G Higgins","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"01","key":"ref201","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/s12879-019-4073-5","article-title":"Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in ICU of the eastern Heilongjiang Province, China","volume":"19","author":"Y Zhao","year":"2019","journal-title":"BMC Infect Dis"},{"key":"ref202","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(94)90694-7","article-title":"Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam","volume":"344","author":"E S Go","year":"1994","journal-title":"Lancet"},{"issue":"01","key":"ref203","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1086\/313902","article-title":"Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage","volume":"31","author":"V M Manikal","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"01","key":"ref204","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1128\/AAC.48.1.224-228.2004","article-title":"Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study","volume":"48","author":"S O Lee","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref205","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13756-018-0430-1","article-title":"Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014","volume":"7","author":"P Yang","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"issue":"09","key":"ref206","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1469-0691.2006.01456.x","article-title":"Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology","volume":"12","author":"L Poirel","year":"2006","journal-title":"Clin Microbiol Infect"},{"issue":"01","key":"ref207","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/1040841X.2016.1160867","article-title":"Prevalence and emergence of carbapenemases-producing Gram-negative bacteria in Mediterranean basin","volume":"43","author":"N Mathlouthi","year":"2017","journal-title":"Crit Rev Microbiol"},{"issue":"03","key":"ref208","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/AAC.01009-09","article-title":"Updated functional classification of beta-lactamases","volume":"54","author":"K Bush","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"05","key":"ref209","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1378\/chest.14-2171","article-title":"Antimicrobial resistance in hospital-acquired gram-negative bacterial infections","volume":"147","author":"B Mehrad","year":"2015","journal-title":"Chest"},{"issue":"04","key":"ref210","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJMra041359","article-title":"The new beta-lactamases","volume":"352","author":"G A Jacoby","year":"2005","journal-title":"N Engl J Med"},{"issue":"07","key":"ref211","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.meegid.2011.06.001","article-title":"Genetic evolution and clinical impact in extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae","volume":"11","author":"Y Chong","year":"2011","journal-title":"Infect Genet Evol"},{"issue":"02","key":"ref212","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/jac\/dkl483","article-title":"CTX-M: changing the face of ESBLs in Europe","volume":"59","author":"D M Livermore","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"02","key":"ref213","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1517\/14656566.2013.763030","article-title":"Evolution of antimicrobial resistance among Enterobacteriaceae (focus on extended spectrum \u03b2-lactamases and carbapenemases)","volume":"14","author":"J P Lynch III","year":"2013","journal-title":"Expert Opin Pharmacother"},{"issue":"03","key":"ref214","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1128\/AAC.43.3.573","article-title":"Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum beta-lactamase encoded by an Escherichia coli integron gene","volume":"43","author":"L Poirel","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"issue":"01","key":"ref215","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/jac\/43.1.157","article-title":"Extended-spectrum beta-lactamase-producing strain of Acinetobacter baumannii isolated from a patient in France","volume":"43","author":"L Poirel","year":"1999","journal-title":"J Antimicrob Chemother"},{"issue":"08","key":"ref216","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3201\/eid1708.051547","article-title":"VEB-1 extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France","volume":"12","author":"T Naas","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"01","key":"ref217","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jac\/dkl178","article-title":"Emergence of PER and VEB extended-spectrum beta-lactamases in Acinetobacter baumannii in Belgium","volume":"58","author":"T Naas","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"09","key":"ref218","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1128\/AAC.00284-06","article-title":"Emergence of PER-2 and VEB-1a in Acinetobacter baumannii strains in the Americas","volume":"50","author":"F Paster\u00e1n","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"05","key":"ref219","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1179\/joc.2010.22.5.324","article-title":"Detection of CTX-M-15-producing and carbapenem-resistant Acinetobacter baumannii strains from urine from an Indian hospital","volume":"22","author":"S Shakil","year":"2010","journal-title":"J Chemother"},{"issue":"12","key":"ref220","doi-asserted-by":"crossref","first-page":"5946","DOI":"10.1128\/AAC.05124-11","article-title":"Genetic features of CTX-M-15-producing Acinetobacter baumannii from Haiti","volume":"55","author":"A Potron","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"03","key":"ref221","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jhin.2015.11.016","article-title":"First report of CTX-M-15-producing Acinetobacter baumannii in Brazil","volume":"92","author":"M C Zago","year":"2016","journal-title":"J Hosp Infect"},{"issue":"12","key":"ref222","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1128\/AAC.00774-09","article-title":"Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India","volume":"53","author":"D Yong","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"20","key":"ref223","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2807\/1560-7917.ES2014.19.20.20809","article-title":"New Delhi metallo-beta-lactamase around the world: an eReview using Google Maps","volume":"19","author":"M Berrazeg","year":"2014","journal-title":"Euro Surveill"},{"issue":"01","key":"ref224","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1128\/AAC.00773-10","article-title":"Carbapenem-hydrolyzing GES-type extended-spectrum beta-lactamase in Acinetobacter baumannii","volume":"55","author":"R A Bonnin","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"ref225","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1128\/AAC.00871-10","article-title":"GES extended-spectrum \u03b2-lactamases in Acinetobacter baumannii isolates in Belgium","volume":"54","author":"P Bogaerts","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref226","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jgar.2016.03.005","article-title":"GES-11-producing Acinetobacter baumannii clinical isolates from Tunisian hospitals: long-term dissemination of GES-type carbapenemases in North Africa","volume":"5","author":"H Chihi","year":"2016","journal-title":"J Glob Antimicrob Resist"},{"key":"ref227","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.micpath.2014.07.003","article-title":"Multidrug-resistant Acinetobacter baumannii strains carrying the bla(OxA-23) and the bla(GES-11) genes in a neonatology center in Tunisia","volume":"74","author":"K Charfi-Kessis","year":"2014","journal-title":"Microb Pathog"},{"issue":"07","key":"ref228","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1017\/ice.2015.52","article-title":"High endemic rates of OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolates caused by the persistence of major clones in hospitals in a Brazilian city 5 years after an outbreak","volume":"36","author":"M Pagano","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"02","key":"ref229","doi-asserted-by":"crossref","first-page":"115242","DOI":"10.1016\/j.diagmicrobio.2020.115242","article-title":"A comprehensive and contemporary \u201csnapshot\u201d of \u03b2-lactamases in carbapenem resistant Acinetobacter baumannii","volume":"99","author":"A M Hujer","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"02","key":"ref230","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0924-8579(93)90045-7","article-title":"ARI 1: beta-lactamase-mediated imipenem resistance in Acinetobacter baumannii","volume":"2","author":"R Paton","year":"1993","journal-title":"Int J Antimicrob Agents"},{"issue":"06","key":"ref231","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3855\/jidc.6640","article-title":"Epidemiological characteristics and antimicrobial susceptibility among carbapenem-resistant non-fermenting bacteria in Brazil","volume":"10","author":"V C Dias","year":"2016","journal-title":"J Infect Dev Ctries"},{"issue":"10","key":"ref232","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1128\/JCM.00699-06","article-title":"Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England","volume":"44","author":"J M Coelho","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"S 01","key":"ref233","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.cmi.2015.09.015","article-title":"National epidemiology of carbapenem-resistant and extensively drug-resistant Gram-negative bacteria isolated from blood samples in China in 2013","volume":"22","author":"A Xu","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"01","key":"ref234","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1128\/AAC.49.1.202-208.2005","article-title":"OXA-58, a novel class D beta-lactamase involved in resistance to carbapenems in Acinetobacter baumannii","volume":"49","author":"L Poirel","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"01","key":"ref235","doi-asserted-by":"crossref","first-page":"e84680","DOI":"10.1371\/journal.pone.0084680","article-title":"Characterization of a novel plasmid type and various genetic contexts of bla OXA-58 in Acinetobacter spp. from multiple cities in China","volume":"9","author":"Y Fu","year":"2014","journal-title":"PLoS One"},{"issue":"04","key":"ref236","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/mdr.2013.0127","article-title":"Nosocomial outbreak of a multiresistant Acinetobacter baumannii expressing OXA-23 carbapenemase in Spain","volume":"20","author":"M Merino","year":"2014","journal-title":"Microb Drug Resist"},{"issue":"11","key":"ref237","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1128\/JCM.00619-11","article-title":"Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States","volume":"49","author":"J M Adams-Haduch","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"02","key":"ref238","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ijantimicag.2014.04.014","article-title":"Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy: considerations on in vitro assay of active drugs","volume":"44","author":"M L Mezzatesta","year":"2014","journal-title":"Int J Antimicrob Agents"},{"issue":"01","key":"ref239","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1089\/mdr.2016.0190","article-title":"Distinct genetic diversity of carbapenem-resistant Acinetobacter baumannii from Colombian Hospitals","volume":"24","author":"A Correa","year":"2018","journal-title":"Microb Drug Resist"},{"issue":"02","key":"ref240","first-page":"276","article-title":"Carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii in the nosocomial setting in Latin America","volume":"42","author":"J A Labarca","year":"2016","journal-title":"Crit Rev Microbiol"},{"issue":"01","key":"ref241","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41426-018-0127-9","article-title":"Emergence and spread of carbapenem-resistant Acinetobacter baumannii international clones II and III in Lima, Peru","volume":"7","author":"S Levy-Blitchtein","year":"2018","journal-title":"Emerg Microbes Infect"},{"issue":"04","key":"ref242","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1128\/AAC.45.4.1151-1161.2001","article-title":"Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae","volume":"45","author":"H Yigit","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"01","key":"ref243","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1086\/421495","article-title":"Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City","volume":"39","author":"P A Bradford","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"10","key":"ref244","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1128\/AAC.49.10.4423-4424.2005","article-title":"Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC in a Klebsiella pneumoniae isolate from France","volume":"49","author":"T Naas","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"03","key":"ref245","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1128\/AAC.02756-15","article-title":"KPC-like carbapenemase-producing Enterobacteriaceae colonizing patients in Europe and Israel","volume":"60","author":"A Baraniak","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"08","key":"ref246","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1099\/jmm.0.000289","article-title":"Genetic environment of the KPC gene in Acinetobacter baumannii ST2 clone from Puerto Rico and genomic insights into its drug resistance","volume":"65","author":"T Martinez","year":"2016","journal-title":"J Med Microbiol"},{"issue":"03","key":"ref247","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1128\/AAC.00899-09","article-title":"Detection of KPC in Acinetobacter spp. in Puerto Rico","volume":"54","author":"I E Robledo","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"08","key":"ref248","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1128\/AAC.00072-09","article-title":"GES-11, a novel integron-associated GES variant in Acinetobacter baumannii","volume":"53","author":"C Moubareck","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"01","key":"ref249","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1128\/AAC.01384-12","article-title":"Wide dissemination of GES-type carbapenemases in Acinetobacter baumannii isolates in Kuwait","volume":"57","author":"R A Bonnin","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"05","key":"ref250","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/1469-0691.12338","article-title":"OXA- and GES-type \u03b2-lactamases predominate in extensively drug-resistant Acinetobacter baumannii isolates from a Turkish University Hospital","volume":"20","author":"A C Cicek","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"09","key":"ref251","doi-asserted-by":"crossref","first-page":"E362","DOI":"10.1111\/j.1469-0691.2012.03928.x","article-title":"Dissemination of New Delhi metallo-\u03b2-lactamase-1-producing Acinetobacter baumannii in Europe","volume":"18","author":"R A Bonnin","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"03","key":"ref252","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1128\/AAC.01497-10","article-title":"Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007","volume":"55","author":"M Castanheira","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"25","key":"ref253","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1056\/NEJMp1011715","article-title":"NDM-1 \u2013 a cause for worldwide concern","volume":"363","author":"R C Moellering Jr","year":"2010","journal-title":"N Engl J Med"},{"issue":"12","key":"ref254","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S1473-3099(10)70279-6","article-title":"Global spread of New Delhi metallo-\u03b2-lactamase 1","volume":"10","author":"L Poirel","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"02","key":"ref255","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijantimicag.2012.05.003","article-title":"Patients transferred from Libya to Denmark carried OXA-48-producing Klebsiella pneumoniae, NDM-1-producing Acinetobacter baumannii and meticillin-resistant Staphylococcus aureus","volume":"40","author":"A M Hammerum","year":"2012","journal-title":"Int J Antimicrob Agents"},{"issue":"06","key":"ref256","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1128\/AAC.04412-14","article-title":"High prevalence of bla(NDM-1) carbapenemase-encoding gene and 16S rRNA armA methyltransferase gene among Acinetobacter baumannii clinical Isolates in Egypt","volume":"59","author":"M A El-Sayed-Ahmed","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"09","key":"ref257","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1093\/jac\/dkr256","article-title":"Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007","volume":"66","author":"Y Pfeifer","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"02","key":"ref258","doi-asserted-by":"crossref","first-page":"E34","DOI":"10.1111\/j.1469-0691.2011.03726.x","article-title":"NDM-2 carbapenemase-producing Acinetobacter baumannii in the United Arab Emirates","volume":"18","author":"A Ghazawi","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"ref259","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.1128\/AAC.00679-11","article-title":"Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation center","volume":"55","author":"P Espinal","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"03","key":"ref260","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jiph.2012.02.003","article-title":"The threat of carbapenem-resistant Enterobacteriaceae in Lebanon: an update on the regional and local epidemiology","volume":"5","author":"R I El-Herte","year":"2012","journal-title":"J Infect Public Health"},{"issue":"06","key":"ref261","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/jac\/dkr135","article-title":"NDM-2 carbapenemase in Acinetobacter baumannii from Egypt","volume":"66","author":"M Kaase","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"01","key":"ref262","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2217\/fmb.13.69","article-title":"New Delhi metallo-\u03b2-lactamase-producing Acinetobacter baumannii: a novel paradigm for spreading antibiotic resistance genes","volume":"9","author":"R A Bonnin","year":"2014","journal-title":"Future Microbiol"},{"issue":"06","key":"ref263","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.apjtm.2015.05.011","article-title":"High prevalence of multidrug-resistance in Acinetobacter baumannii and dissemination of carbapenemase-encoding genes blaOXA-23-like, blaOXA-24-like and blaNDM-1 in Algiers hospitals","volume":"8","author":"K Khorsi","year":"2015","journal-title":"Asian Pac J Trop Med"},{"issue":"01","key":"ref264","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijantimicag.2016.03.007","article-title":"Early detection of metallo-\u03b2-lactamase NDM-1- and OXA-23 carbapenemase-producing Acinetobacter baumannii in Libyan hospitals","volume":"48","author":"N Mathlouthi","year":"2016","journal-title":"Int J Antimicrob Agents"},{"issue":"31","key":"ref265","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2807\/1560-7917.ES2013.18.31.20547","article-title":"Outbreak of NDM-1-producing Acinetobacter baumannii in France, January to May 2013","volume":"18","author":"J W Decousser","year":"2013","journal-title":"Euro Surveill"},{"issue":"04","key":"ref266","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1128\/AAC.05653-11","article-title":"NDM-1-producing Acinetobacter baumannii from Algeria","volume":"56","author":"A Boulanger","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"02","key":"ref267","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1128\/AAC.01247-10","article-title":"Detection of NDM-1-producing Klebsiella pneumoniae in Kenya","volume":"55","author":"L Poirel","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"05","key":"ref268","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s10096-013-2024-4","article-title":"Emergence of NDM-producing non-baumannii Acinetobacter spp. isolated from China","volume":"33","author":"R Zhang","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"08","key":"ref269","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.1128\/AAC.04682-14","article-title":"NDM-1-producing Citrobacter freundii, Escherichia coli, and Acinetobacter baumannii identified from a single patient in China","volume":"59","author":"Y M Huang","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"02","key":"ref270","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s10156-012-0469-5","article-title":"A case of NDM-1-producing Acinetobacter baumannii transferred from India to Japan","volume":"19","author":"Y Nakazawa","year":"2013","journal-title":"J Infect Chemother"},{"issue":"06","key":"ref271","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/jac\/dkr082","article-title":"Emergence of NDM-1-producing Acinetobacter baumannii in China","volume":"66","author":"Y Chen","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"ref272","doi-asserted-by":"crossref","first-page":"E506","DOI":"10.1111\/1469-0691.12035","article-title":"Dissemination and characterization of NDM-1-producing Acinetobacter pittii in an intensive care unit in China","volume":"18","author":"J Yang","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"06","key":"ref273","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1089\/mdr.2017.0078","article-title":"Prevalence and molecular characterization of New Delhi metallo-beta-lactamases in multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii from India","volume":"24","author":"M Rahman","year":"2018","journal-title":"Microb Drug Resist"},{"issue":"01","key":"ref274","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13756-020-00769-8","article-title":"The first nationwide multicenter study of Acinetobacter baumannii recovered in Serbia: emergence of OXA-72, OXA-23 and NDM-1-producing isolates","volume":"9","author":"B Lukovic","year":"2020","journal-title":"Antimicrob Resist Infect Control"},{"issue":"05","key":"ref275","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1016\/j.ijid.2012.11.025","article-title":"Emergence of New Delhi metallo-\u03b2-lactamase type 1-producing Enterobacteriaceae and non-Enterobacteriaceae: global case detection and bacterial surveillance","volume":"17","author":"G Bushnell","year":"2013","journal-title":"Int J Infect Dis"},{"issue":"15","key":"ref276","doi-asserted-by":"crossref","first-page":"e00793","DOI":"10.1128\/AEM.00793-17","article-title":"Environmental spread of New Delhi metallo-\u03b2-lactamase-1-producing multidrug-resistant bacteria in Dhaka, Bangladesh","volume":"83","author":"M A Islam","year":"2017","journal-title":"Appl Environ Microbiol"},{"issue":"10","key":"ref277","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3390\/antibiotics9100675","article-title":"Antibiotic resistance and mobile genetic elements in extensively drug-resistant Klebsiella pneumoniae sequence type 147 recovered from Germany","volume":"9","author":"K Xanthopoulou","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"ref278","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jgar.2016.10.004","article-title":"First report of NDM-1-producing Klebsiella pneumoniae imported from Africa to Italy: evidence of the need for continuous surveillance","volume":"8","author":"L Principe","year":"2017","journal-title":"J Glob Antimicrob Resist"},{"key":"ref279","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.2147\/IDR.S259562","article-title":"Carbapenemase producing gram-negative bacteria in Tunisia: history of thirteen years of challenge","volume":"13","author":"O Dziri","year":"2020","journal-title":"Infect Drug Resist"},{"issue":"04","key":"ref280","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ijantimicag.2014.12.011","article-title":"Emergence of NDM-1-producing Acinetobacter pittii in Brazil","volume":"45","author":"M Pagano","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"e190020","DOI":"10.1590\/0074-02760190020","article-title":"Diversity of metallo-\u03b2-lactamase-encoding genes found in distinct species of Acinetobacter isolated from the Brazilian Amazon Region","volume":"114","author":"D Brasiliense","year":"2019","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"12","key":"ref282","doi-asserted-by":"crossref","first-page":"7592","DOI":"10.1128\/AAC.03444-14","article-title":"First report of NDM-1-producing Acinetobacter baumannii sequence type 25 in Brazil","volume":"58","author":"M Pillonetto","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"09","key":"ref283","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1093\/jac\/dku139","article-title":"Emergence of genetically unrelated NDM-1-producing Acinetobacter pittii strains in Paraguay","volume":"69","author":"F Pasteran","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"ref284","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.nmni.2016.02.008","article-title":"Presence of New Delhi metallo-\u03b2-lactamase gene (NDM-1) in a clinical isolate of Acinetobacter junii in Argentina","volume":"11","author":"S Monta\u00f1a","year":"2016","journal-title":"New Microbes New Infect"},{"issue":"09","key":"ref285","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1128\/AAC.00275-13","article-title":"Bacterial peritonitis due to Acinetobacter baumannii sequence type 25 with plasmid-borne new Delhi metallo-\u03b2-lactamase in Honduras","volume":"57","author":"P E Waterman","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"ref286","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1097\/CCM.0b013e318298a541","article-title":"Eighteen years of experience with Acinetobacter baumannii in a tertiary care hospital","volume":"41","author":"L S Munoz-Price","year":"2013","journal-title":"Crit Care Med"},{"issue":"02","key":"ref287","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40121-017-0153-2","article-title":"Minocycline for the treatment of multidrug and extensively drug-resistant A. baumannii: a review","volume":"6","author":"J N Lashinsky","year":"2017","journal-title":"Infect Dis Ther"},{"issue":"03","key":"ref288","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.diagmicrobio.2014.03.027","article-title":"In vivo emergence of colistin resistance in Acinetobacter baumannii clinical isolates of sequence type 357 during colistin treatment","volume":"79","author":"Y Kim","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"07","key":"ref289","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/jac\/dks084","article-title":"Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies","volume":"67","author":"Y Cai","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"ref290","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1017\/ice.2016.174","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014","volume":"37","author":"L M Weiner","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"07","key":"ref291","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10661-018-6801-5","article-title":"Detection of different \u03b2-lactamases encoding genes, including blaNDM, and plasmid-mediated quinolone resistance genes in different water sources from Brazil","volume":"190","author":"D G Sanchez","year":"2018","journal-title":"Environ Monit Assess"},{"issue":"04","key":"ref292","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.diagmicrobio.2009.08.020","article-title":"Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008)","volume":"65","author":"P R Rhomberg","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"03","key":"ref293","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1089\/mdr.2010.0052","article-title":"Acinetobacter baumannii 2002-2008: increase of carbapenem-associated multiclass resistance in the United States","volume":"16","author":"R M Mera","year":"2010","journal-title":"Microb Drug Resist"},{"issue":"03","key":"ref294","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.diagmicrobio.2012.04.002","article-title":"Multidrug resistance among Acinetobacter spp. in the USA and activity profile of key agents: results from CAPITAL Surveillance 2010","volume":"73","author":"A M Queenan","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref295","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1476-0711-12-24","article-title":"Antimicrobial susceptibility among gram-negative isolates collected in the USA between 2005 and 2011 as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.)","volume":"12","author":"G A Denys","year":"2013","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"01","key":"ref296","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/ice.2019.296","article-title":"Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: summary of data reported to the National Healthcare Safety Network, 2015-2017","volume":"41","author":"L M Weiner-Lastinger","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"06","key":"ref297","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.bjid.2013.07.002","article-title":"Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011)","volume":"17","author":"R N Jones","year":"2013","journal-title":"Braz J Infect Dis"},{"issue":"06","key":"ref298","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jmii.2012.08.006","article-title":"Dissemination of multidrug-resistant Acinetobacter baumannii carrying BlaOxA-23 from hospitals in central Taiwan","volume":"46","author":"M H Lee","year":"2013","journal-title":"J Microbiol Immunol Infect"},{"issue":"01","key":"ref299","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.00042-16","article-title":"Carbapenem-resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia","volume":"30","author":"L Y Hsu","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"ref300","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.3389\/fmicb.2017.02479","article-title":"Acinetobacter spp. infections in Malaysia: a review of antimicrobial resistance trends, mechanisms and epidemiology","volume":"8","author":"F Mohd Rani","year":"2017","journal-title":"Front Microbiol"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"100779","DOI":"10.1016\/j.nmni.2020.100779","article-title":"Evaluating the frequency of carbapenem and aminoglycoside resistance genes among clinical isolates of Acinetobacter baumannii from Ahvaz, south-west Iran","volume":"38","author":"S M Mortazavi","year":"2020","journal-title":"New Microbes New Infect"},{"issue":"05","key":"ref302","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/jac\/dkr056","article-title":"Comparative activity of carbapenem testing: the COMPACT study","volume":"66","author":"P Nordmann","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"ref303","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jgar.2018.05.024","article-title":"Trends and factors associated with antimicrobial resistance of Acinetobacter spp. invasive isolates in Europe: a country-level analysis","volume":"14","author":"G Alvarez-Uria","year":"2018","journal-title":"J Glob Antimicrob Resist"},{"issue":"07","key":"ref304","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10096-008-0473-y","article-title":"Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance","volume":"27","author":"D W Wareham","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"06","key":"ref305","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.ijantimicag.2016.09.006","article-title":"First report of an NDM-1 metallo-\u03b2-lactamase-producing Acinetobacter baumannii clinical isolate in Greece","volume":"48","author":"E Voulgari","year":"2016","journal-title":"Int J Antimicrob Agents"},{"issue":"06","key":"ref306","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3906\/sag-1309-126","article-title":"Detection of the frequency of PER-1 type extended-spectrum \u03b2-lactamase-producing Acinetobacter baumannii clinical isolates in Turkey: a multicenter study","volume":"44","author":"G A\u015fik","year":"2014","journal-title":"Turk J Med Sci"},{"issue":"01","key":"ref307","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12941-018-0301-x","article-title":"Prevalence of Acinetobacter baumannii in Saudi Arabia: risk factors, antimicrobial resistance patterns and mechanisms of carbapenem resistance","volume":"18","author":"M E Ibrahim","year":"2019","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"01","key":"ref308","first-page":"65","article-title":"Characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates in a tertiary care hospital in Saudi Arabia","volume":"37","author":"B Abdalhamid","year":"2014","journal-title":"New Microbiol"},{"key":"ref309","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12941-015-0098-9","article-title":"Molecular characterization of extended-spectrum beta-lactamases (ESBLs) produced by clinical isolates of Acinetobacter baumannii in Saudi Arabia","volume":"14","author":"E J Alyamani","year":"2015","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"03","key":"ref310","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1089\/mdr.2018.0435","article-title":"Prevalence and mechanisms of carbapenem resistance in Acinetobacter baumannii: a comprehensive systematic review of cross-sectional studies from Iran","volume":"26","author":"M J Nasiri","year":"2020","journal-title":"Microb Drug Resist"},{"issue":"11","key":"ref311","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1128\/AAC.00633-13","article-title":"Spread of carbapenem-resistant Acinetobacter baumannii global clone 2 in Asia and AbaR-type resistance islands","volume":"57","author":"D H Kim","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"04","key":"ref312","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/jac\/dkq027","article-title":"Wide dissemination of OXA-23-producing carbapenem-resistant Acinetobacter baumannii clonal complex 22 in multiple cities of China","volume":"65","author":"Y Fu","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"ref313","doi-asserted-by":"crossref","first-page":"9461901","DOI":"10.1155\/2020\/9461901","article-title":"Carbapenemase-producing non-glucose-fermenting gram-negative bacilli in Africa, Pseudomonas aeruginosa and Acinetobacter baumannii: a systematic review and meta-analysis","volume":"2020","author":"M Kindu","year":"2020","journal-title":"Int J Microbiol"},{"issue":"01","key":"ref314","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1186\/s12879-017-2713-1","article-title":"Antimicrobial resistance in Africa: a systematic review","volume":"17","author":"B T Tadesse","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"01","key":"ref315","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/mdr.2015.0053","article-title":"The molecular epidemiology and genetic environment of carbapenemases detected in Africa","volume":"22","author":"J O Sekyere","year":"2016","journal-title":"Microb Drug Resist"},{"key":"ref316","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.3389\/fmicb.2018.01280","article-title":"Acinetobacter baumannii: epidemiological and beta-lactamase data from two tertiary academic hospitals in Tshwane, South Africa","volume":"9","author":"M Lowe","year":"2018","journal-title":"Front Microbiol"},{"issue":"03","key":"ref317","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/mdr.2017.0057","article-title":"Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in a tertiary care hospital in Egypt: clonal spread of blaOXA-23","volume":"24","author":"A MS El Bannah","year":"2018","journal-title":"Microb Drug Resist"},{"key":"ref318","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13756-019-0611-6","article-title":"Phenotypic and genotypic characterization of carbapenem-resistant Acinetobacter baumannii isolates from Egypt","volume":"8","author":"A Abouelfetouh","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"issue":"09","key":"ref319","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/cid\/ciy375","article-title":"Acinetobacter pneumonia: improving outcomes with early identification and appropriate therapy","volume":"67","author":"C Vazquez Guillamet","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"06","key":"ref320","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/jac\/dkn128","article-title":"Ampicillin\/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp","volume":"61","author":"M S Oliveira","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"04","key":"ref321","doi-asserted-by":"crossref","first-page":"e02534","DOI":"10.1128\/AAC.02534-19","article-title":"In vitro activity of sulbactam-durlobactam against Acinetobacter baumannii-calcoaceticus complex isolates collected globally in 2016 and 2017","volume":"64","author":"S M McLeod","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"09","key":"ref322","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1177\/0885066616632193","article-title":"Multidrug resistance Acinetobacter bacteremia secondary to ventilator-associated pneumonia: risk factors and outcome","volume":"32","author":"E Brotfain","year":"2017","journal-title":"J Intensive Care Med"},{"issue":"07","key":"ref323","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1128\/AAC.00342-13","article-title":"Pharmacodynamics modeling to optimize dosage regimens of sulbactam","volume":"57","author":"S Jaruratanasirikul","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"06","key":"ref324","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jinf.2008.04.002","article-title":"Efficacy and safety of high-dose ampicillin\/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia","volume":"56","author":"A P Betrosian","year":"2008","journal-title":"J Infect"},{"issue":"04","key":"ref325","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/1120009X.2016.1143261","article-title":"Determination of synergy between sulbactam, meropenem and colistin in carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii isolates and correlation with the molecular mechanism of resistance","volume":"28","author":"S Laishram","year":"2016","journal-title":"J Chemother"},{"issue":"03","key":"ref326","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1128\/AAC.01947-17","article-title":"Molecular epidemiology and mechanism of sulbactam resistance in Acinetobacter baumannii isolates with diverse genetic backgrounds in China","volume":"62","author":"Y Yang","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"ref327","doi-asserted-by":"crossref","first-page":"e1234","DOI":"10.1016\/j.ijid.2013.05.002","article-title":"Successful treatment of skin and soft tissue infection due to carbapenem-resistant Acinetobacter baumannii by ampicillin-sulbactam and meropenem combination therapy","volume":"17","author":"Y Hiraki","year":"2013","journal-title":"Int J Infect Dis"},{"issue":"02","key":"ref328","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ijantimicag.2017.10.016","article-title":"Genomic analysis of in vivo acquired resistance to colistin and rifampicin in Acinetobacter baumannii","volume":"51","author":"N Jaidane","year":"2018","journal-title":"Int J Antimicrob Agents"},{"issue":"01","key":"ref329","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/cid\/ciu213","article-title":"Colistin and polymyxin B: peas in a pod, or chalk and cheese?","volume":"59","author":"R L Nation","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"03","key":"ref330","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/cid\/ciu319","article-title":"The antimicrobial resistance monitoring and research (ARMoR) program: the US Department of Defense response to escalating antimicrobial resistance","volume":"59","author":"E P Lesho","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"09","key":"ref331","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1093\/jac\/dku170","article-title":"Detection of pan drug-resistant Acinetobacter baumannii in Germany","volume":"69","author":"S G\u00f6ttig","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"09","key":"ref332","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/cid\/cir611","article-title":"Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system","volume":"53","author":"J M Pogue","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"02","key":"ref333","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/FTD.0b013e3182a8997c","article-title":"Determination by LC-MS\/MS of colistins A and B in plasma and ultrafiltrate from critically ill patients undergoing continuous venovenous hemodiafiltration","volume":"36","author":"M Leporati","year":"2014","journal-title":"Ther Drug Monit"},{"issue":"03","key":"ref334","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1186\/cc13858","article-title":"High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria","volume":"18","author":"G De Pascale","year":"2014","journal-title":"Crit Care"},{"issue":"11","key":"ref335","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1093\/jac\/dkw293","article-title":"Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii: pharmacodynamics of new dosing strategies","volume":"71","author":"G G Rao","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"07","key":"ref336","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1128\/AAC.02927-15","article-title":"Colistin and polymyxin B dosage regimens against Acinetobacter baumannii: differences in activity and the emergence of resistance","volume":"60","author":"S E Cheah","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"ref337","doi-asserted-by":"crossref","first-page":"26233","DOI":"10.1038\/srep26233","article-title":"Polymyxin resistance in Acinetobacter baumannii: genetic mutations and transcriptomic changes in response to clinically relevant dosage regimens","volume":"6","author":"S E Cheah","year":"2016","journal-title":"Sci Rep"},{"issue":"10","key":"ref338","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1097\/01.CCM.0000089936.09573.F3","article-title":"Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study","volume":"31","author":"J Garnacho","year":"2003","journal-title":"Crit Care Med"},{"issue":"08","key":"ref339","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s10096-014-2070-6","article-title":"Comparison of colistin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections","volume":"33","author":"A Batirel","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"11","key":"ref340","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1093\/jac\/dku233","article-title":"Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: analysis of a multicentre prospective cohort","volume":"69","author":"L E L\u00f3pez-Cort\u00e9s","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"ref341","doi-asserted-by":"crossref","first-page":"e52349","DOI":"10.1371\/journal.pone.0052349","article-title":"Epidemiology, clinical characteristics and outcomes of extensively drug-resistant Acinetobacter baumannii infections among solid organ transplant recipients","volume":"7","author":"R K Shields","year":"2012","journal-title":"PLoS One"},{"issue":"04","key":"ref342","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1473-3099(18)30099-9","article-title":"Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial","volume":"18","author":"M Paul","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"05","key":"ref343","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/cid\/ciy988","article-title":"Treatment outcomes of colistin- and carbapenem-resistant Acinetobacter baumannii infections: an exploratory subgroup analysis of a randomized clinical trial","volume":"69","author":"Y Dickstein","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"06","key":"ref344","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/CCM.0000000000000933","article-title":"Excess mortality associated with colistin-tigecycline compared with colistin-carbapenem combination therapy for extensively drug-resistant Acinetobacter baumannii bacteremia: a multicenter prospective observational study","volume":"43","author":"A Cheng","year":"2015","journal-title":"Crit Care Med"},{"issue":"02","key":"ref345","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.diagmicrobio.2016.07.017","article-title":"In vitro antimicrobial synergy of colistin with rifampicin and carbapenems against colistin-resistant Acinetobacter baumannii clinical isolates","volume":"86","author":"D J Hong","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"02","key":"ref346","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3343\/alm.2016.36.2.124","article-title":"In vitro interactions of antibiotic combinations of colistin, tigecycline, and doripenem against extensively drug-resistant and multidrug-resistant Acinetobacter baumannii","volume":"36","author":"G C Park","year":"2016","journal-title":"Ann Lab Med"},{"issue":"05","key":"ref347","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ijantimicag.2016.07.018","article-title":"Synergistic killing by meropenem and colistin combination of carbapenem-resistant Acinetobacter baumannii isolates from Chinese patients in an in vitro pharmacokinetic\/pharmacodynamic model","volume":"48","author":"X Liu","year":"2016","journal-title":"Int J Antimicrob Agents"},{"issue":"01","key":"ref348","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/jac\/dkx368","article-title":"Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis","volume":"73","author":"K Kengkla","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"ref349","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jgar.2020.08.021","article-title":"Comparative efficacy and safety of combination therapy with high-dose sulbactam or colistin with additional antibacterial agents for multiple drug-resistant and extensively drug-resistant Acinetobacter baumannii infections: a systematic review and network meta-analysis","volume":"24","author":"J Liu","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"issue":"03","key":"ref350","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000356004","article-title":"Clinical efficacy and safety of the combination of colistin plus vancomycin for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii","volume":"59","author":"J Garnacho-Montero","year":"2013","journal-title":"Chemotherapy"},{"issue":"02","key":"ref351","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1128\/AAC.00871-13","article-title":"Clinical experience of colistin-glycopeptide combination in critically ill patients infected with Gram-negative bacteria","volume":"58","author":"N Petrosillo","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"02","key":"ref352","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","article-title":"Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study","volume":"16","author":"Y Y Liu","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"03","key":"ref353","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(16)00006-2","article-title":"Plasmid-mediated carbapenem and colistin resistance in a clinical isolate of Escherichia coli","volume":"16","author":"L Poirel","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"ref354","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/cid\/ciw124","article-title":"Plasmid-mediated colistin-resistant Escherichia coli in bacteremia in Switzerland","volume":"62","author":"P Nordmann","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"09","key":"ref355","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.3201\/eid2209.160177","article-title":"mcr-1-Positive colistin-resistant Escherichia coli in traveler returning to Canada from China","volume":"22","author":"M Payne","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"08","key":"ref356","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1038\/emi.2016.85","article-title":"Transmissible colistin resistance encoded by mcr-1 detected in clinical Enterobacteriaceae isolates in Singapore","volume":"5","author":"J W Teo","year":"2016","journal-title":"Emerg Microbes Infect"},{"issue":"07","key":"ref357","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/infdis\/jir475","article-title":"Acinetobacter baumannii resistant to colistin with impaired virulence: a case report from France","volume":"204","author":"J M Rolain","year":"2011","journal-title":"J Infect Dis"},{"issue":"04","key":"ref358","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/infdis\/jiq086","article-title":"Impaired virulence and in vivo fitness of colistin-resistant Acinetobacter baumannii","volume":"203","author":"R L\u00f3pez-Rojas","year":"2011","journal-title":"J Infect Dis"},{"issue":"05","key":"ref359","doi-asserted-by":"crossref","first-page":"314","DOI":"10.4103\/2319-4170.132879","article-title":"Influencing factors of successful eradication of multidrug-resistant Acinetobacter baumannii in the respiratory tract with aerosolized colistin","volume":"37","author":"Y M Chen","year":"2014","journal-title":"Biomed J"},{"issue":"12","key":"ref360","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1080\/14740338.2020.1819980","article-title":"Intravenous vs intravenous plus aerosolized colistin for treatment of ventilator-associated pneumonia - a matched case-control study in neonates","volume":"19","author":"K Hussain","year":"2020","journal-title":"Expert Opin Drug Saf"},{"issue":"04","key":"ref361","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jinf.2018.02.002","article-title":"Intravenous plus inhaled versus intravenous colistin monotherapy for lower respiratory tract infections: a systematic review and meta-analysis","volume":"76","author":"K Z Vardakas","year":"2018","journal-title":"J Infect"},{"issue":"12","key":"ref362","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1177\/1060028017723934","article-title":"An update on aerosolized antibiotics for treating hospital-acquired and ventilator-associated pneumonia in adults","volume":"51","author":"G C Wood","year":"2017","journal-title":"Ann Pharmacother"},{"key":"ref363","doi-asserted-by":"crossref","first-page":"1753466619885529","DOI":"10.1177\/1753466619885529","article-title":"Inhalation with intravenous loading dose of colistin in critically ill patients with pneumonia caused by carbapenem-resistant gram-negative bacteria","volume":"13","author":"J Choe","year":"2019","journal-title":"Ther Adv Respir Dis"},{"issue":"04","key":"ref364","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1089\/mdr.2016.0043","article-title":"Minocycline and tigecycline: what is their role in the treatment of carbapenem-resistant gram-negative organisms?","volume":"23","author":"C Shankar","year":"2017","journal-title":"Microb Drug Resist"},{"issue":"05","key":"ref365","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ijantimicag.2014.12.031","article-title":"Tetracyclines for multidrug-resistant Acinetobacter baumannii infections","volume":"45","author":"M E Falagas","year":"2015","journal-title":"Int J Antimicrob Agents"},{"issue":"S 06","key":"ref366","doi-asserted-by":"crossref","first-page":"S367","DOI":"10.1093\/cid\/ciu706","article-title":"Update on Acinetobacter species: mechanisms of antimicrobial resistance and contemporary in vitro activity of minocycline and other treatment options","volume":"59","author":"M Castanheira","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"09","key":"ref367","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/cid\/civ048","article-title":"Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance","volume":"60","author":"Z A Qureshi","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"04","key":"ref368","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijantimicag.2014.06.015","article-title":"Global transcriptional response of Acinetobacter baumannii to a subinhibitory concentration of tigecycline","volume":"44","author":"X Hua","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"ref369","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12941-015-0085-1","article-title":"Global in vitro activity of tigecycline and comparator agents: tigecycline evaluation and surveillance trial 2004-2013","volume":"14","author":"D J Hoban","year":"2015","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"03","key":"ref370","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5414\/CP203102","article-title":"Comparison of the treatment efficacy between tigecycline plus high-dose cefoperazone-sulbactam and tigecycline monotherapy against ventilator-associated pneumonia caused by extensively drug-resistant Acinetobacter baumannii","volume":"56","author":"Y Qin","year":"2018","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"10","key":"ref371","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.ajic.2011.12.014","article-title":"Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and\/or carbapenem-resistant Enterobacteriaceae infections","volume":"40","author":"K Ku","year":"2012","journal-title":"Am J Infect Control"},{"issue":"09","key":"ref372","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s10096-013-1870-4","article-title":"Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections","volume":"32","author":"Y T Lee","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"02","key":"ref373","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.diagmicrobio.2010.05.012","article-title":"Comparison of tigecycline with imipenem\/cilastatin for the treatment of hospital-acquired pneumonia","volume":"68","author":"A T Freire","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref374","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-2334-14-102","article-title":"Effectiveness of tigecycline-based versus colistin- based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumannii in a critical setting: a matched cohort analysis","volume":"14","author":"Y C Chuang","year":"2014","journal-title":"BMC Infect Dis"},{"key":"ref375","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s12879-016-1717-6","article-title":"Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex","volume":"16","author":"J J Ye","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"12","key":"ref376","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1093\/cid\/cis270","article-title":"Excess deaths associated with tigecycline after approval based on noninferiority trials","volume":"54","author":"P Prasad","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"03","key":"ref377","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1128\/AAC.04809-14","article-title":"Activity of eravacycline against Enterobacteriaceae and Acinetobacter baumannii, including multidrug-resistant isolates, from New York City","volume":"59","author":"M Abdallah","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"06","key":"ref378","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1128\/AAC.00436-16","article-title":"In vitro activity of eravacycline against carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii","volume":"60","author":"D M Livermore","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"01","key":"ref379","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijantimicag.2017.06.022","article-title":"In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumannii","volume":"51","author":"H Seifert","year":"2018","journal-title":"Int J Antimicrob Agents"},{"issue":"12","key":"ref380","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/phar.2476","article-title":"Cefiderocol: a novel siderophore cephalosporin against multidrug-resistant gram-negative pathogens","volume":"40","author":"J C Abdul-Mutakabbir","year":"2020","journal-title":"Pharmacotherapy"},{"issue":"07","key":"ref381","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1089\/mdr.2019.0298","article-title":"Activity of cefiderocol against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii endemic to medical centers in New York City","volume":"26","author":"A Iregui","year":"2020","journal-title":"Microb Drug Resist"},{"issue":"11","key":"ref382","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1093\/cid\/ciaa1410","article-title":"Cefiderocol as rescue therapy for Acinetobacter baumannii and other carbapenem-resistant gram-negative infections in ICU patients","volume":"72","author":"M Falcone","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"01","key":"ref383","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s40121-020-00357-8","article-title":"Efficacy of a fosfomycin-containing regimen for treatment of severe pneumonia caused by multidrug-resistant Acinetobacter baumannii: a prospective, observational study","volume":"10","author":"A Russo","year":"2021","journal-title":"Infect Dis Ther"},{"key":"ref384","doi-asserted-by":"crossref","first-page":"114400","DOI":"10.1016\/j.bcp.2020.114400","article-title":"Comparative metabolomics reveals key pathways associated with the synergistic activity of polymyxin B and rifampicin combination against multidrug-resistant Acinetobacter baumannii","volume":"184","author":"J Zhao","year":"2021","journal-title":"Biochem Pharmacol"},{"issue":"06","key":"ref385","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1017\/S095026881200194X","article-title":"Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia","volume":"141","author":"H Aydemir","year":"2013","journal-title":"Epidemiol Infect"},{"issue":"03","key":"ref386","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/cid\/cit253","article-title":"Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial","volume":"57","author":"E Durante-Mangoni","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"04","key":"ref387","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1556\/030.66.2019.040","article-title":"Fluoroquinolone resistance conferred by gyrA, parC mutations, and AbaQ efflux pump among Acinetobacter baumannii clinical isolates causing ventilator-associated pneumonia","volume":"67","author":"N M Attia","year":"2019","journal-title":"Acta Microbiol Immunol Hung"},{"issue":"01","key":"ref388","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/ijmm.IJMM_17_225","article-title":"High-level aminoglycoside resistance in Acinetobacter baumannii recovered from Intensive Care Unit patients in Northeastern India","volume":"36","author":"S Upadhyay","year":"2018","journal-title":"Indian J Med Microbiol"},{"key":"ref389","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.meegid.2018.09.028","article-title":"Diversity of aminoglycoside modifying enzymes and 16S rRNA methylases in Acinetobacter baumannii and Acinetobacter nosocomialis species in Iran; wide distribution of aadA1 and armA","volume":"66","author":"H Salimizand","year":"2018","journal-title":"Infect Genet Evol"},{"issue":"01","key":"ref390","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0195-6701(90)90024-I","article-title":"Nosocomial outbreaks due to amikacin-resistant tobramycin-sensitive Acinetobacter species: correlation with amikacin usage","volume":"15","author":"Y Buisson","year":"1990","journal-title":"J Hosp Infect"},{"issue":"06","key":"ref391","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1128\/JCM.00359-16","article-title":"Anatomic, geographic, and taxon-specific relative risks of carbapenem resistance in the health care system of the U.S. Department of Defense","volume":"54","author":"E Lesho","year":"2016","journal-title":"J Clin Microbiol"},{"key":"ref392","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1099\/jmm.0.45716-0","article-title":"Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones","volume":"53","author":"A Nemec","year":"2004","journal-title":"J Med Microbiol"},{"issue":"01","key":"ref393","first-page":"e01110","article-title":"New treatment options against carbapenem-resistant Acinetobacter baumannii infections","volume":"63","author":"B Isler","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"08","key":"ref394","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.cmi.2019.03.014","article-title":"Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment","volume":"25","author":"E T Piperaki","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"ref395","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1586\/eri.11.107","article-title":"Will new antimicrobials overcome resistance among Gram-negatives?","volume":"9","author":"M Bassetti","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"04","key":"ref396","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ijantimicag.2015.12.021","article-title":"New drugs for the treatment of complicated intra-abdominal infections in the era of increasing antimicrobial resistance","volume":"47","author":"L S Syue","year":"2016","journal-title":"Int J Antimicrob Agents"},{"issue":"05","key":"ref397","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/jac\/dks009","article-title":"In vitro activity of the siderophore monosulfactam BAL30072 against meropenem-non-susceptible Acinetobacter baumannii","volume":"67","author":"P G Higgins","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"04","key":"ref398","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ijantimicag.2011.06.006","article-title":"Pre-clinical studies of a new quinolone (UB-8902) against Acinetobacter baumannii resistant to ciprofloxacin","volume":"38","author":"R L\u00f3pez-Rojas","year":"2011","journal-title":"Int J Antimicrob Agents"},{"issue":"02","key":"ref399","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s40265-013-0013-7","article-title":"Ceftazidime-avibactam: a novel cephalosporin\/\u03b2-lactamase inhibitor combination","volume":"73","author":"G G Zhanel","year":"2013","journal-title":"Drugs"},{"issue":"05","key":"ref400","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/MCC.0000000000000235","article-title":"New antibiotics and antimicrobial combination therapy for the treatment of gram-negative bacterial infections","volume":"21","author":"M Bassetti","year":"2015","journal-title":"Curr Opin Crit Care"},{"issue":"02","key":"ref401","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/cid\/ciw243","article-title":"Ceftazidime\/Avibactam and ceftolozane\/tazobactam: second-generation \u03b2-lactam\/\u03b2-lactamase inhibitor combinations","volume":"63","author":"D van Duin","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"01","key":"ref402","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40265-013-0168-2","article-title":"Ceftolozane\/tazobactam: a novel cephalosporin\/\u03b2-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli","volume":"74","author":"G G Zhanel","year":"2014","journal-title":"Drugs"},{"issue":"10","key":"ref403","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1128\/AAC.00873-15","article-title":"Can plazomicin alone or in combination be a therapeutic option against carbapenem-resistant Acinetobacter baumannii?","volume":"59","author":"C Garc\u00eda-Salguero","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"04","key":"ref404","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1586\/eri.12.25","article-title":"Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin","volume":"10","author":"G G Zhanel","year":"2012","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"02","key":"ref405","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/QCO.0000000000000438","article-title":"New antibiotics for ventilator-associated pneumonia","volume":"31","author":"M Bassetti","year":"2018","journal-title":"Curr Opin Infect Dis"},{"issue":"01","key":"ref406","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.diagmicrobio.2010.08.014","article-title":"Novel bis-indole agents active against multidrug-resistant Acinetobacter baumannii","volume":"69","author":"M R Jacobs","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"05","key":"ref407","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.bmcl.2012.11.073","article-title":"Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE), Part II: development of inhibitors with broad spectrum, Gram-negative antibacterial activity","volume":"23","author":"M Trzoss","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"ref408","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/nyas.12005","article-title":"Peptide antimicrobials: cell wall as a bacterial target","volume":"1277","author":"N Y Yount","year":"2013","journal-title":"Ann N Y Acad Sci"},{"issue":"04","key":"ref409","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1469-0691.2011.03581.x","article-title":"In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii","volume":"18","author":"X Vila-Farres","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"ref410","doi-asserted-by":"crossref","first-page":"e00954","DOI":"10.1128\/AAC.00954-17","article-title":"Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection","volume":"61","author":"R T Schooley","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"04","key":"ref411","doi-asserted-by":"crossref","first-page":"ofy064","DOI":"10.1093\/ofid\/ofy064","article-title":"Phage therapy for a multidrug-resistant Acinetobacter baumannii craniectomy site infection","volume":"5","author":"S LaVergne","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"04","key":"ref412","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ajic.2009.07.012","article-title":"Management of a multidrug-resistant Acinetobacter baumannii outbreak in an intensive care unit using novel environmental disinfection: a 38-month report","volume":"38","author":"C La Forgia","year":"2010","journal-title":"Am J Infect Control"},{"issue":"08","key":"ref413","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.ajic.2016.01.041","article-title":"Hospital air: a potential route for transmission of infections caused by \u03b2-lactam-resistant bacteria","volume":"44","author":"S H Mirhoseini","year":"2016","journal-title":"Am J Infect Control"},{"issue":"05","key":"ref414","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1086\/670209","article-title":"Acinetobacter baumannii: association between environmental contamination of patient rooms and occupant status","volume":"34","author":"L S Munoz-Price","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"02","key":"ref415","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.burns.2014.07.014","article-title":"The activity of silver nanoparticles (Axonnite) on clinical and environmental strains of Acinetobacter spp","volume":"41","author":"M E \u0141ysakowska","year":"2015","journal-title":"Burns"},{"issue":"07","key":"ref416","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ajic.2014.03.354","article-title":"Impact of daily chlorhexidine baths and hand hygiene compliance on nosocomial infection rates in critically ill patients","volume":"42","author":"M F Mart\u00ednez-Res\u00e9ndez","year":"2014","journal-title":"Am J Infect Control"}],"container-title":["Seminars in Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1741019.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T23:45:52Z","timestamp":1645055152000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0041-1741019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":416,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2022,2,16]]},"published-print":{"date-parts":[[2022,2]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1741019","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1069-3424","1098-9048"],"issn-type":[{"value":"1069-3424","type":"print"},{"value":"1098-9048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2]]}}}